Latest Kava News

The Calmer Co. International Limited has reported a striking 86% revenue jump to over AU$8 million in FY25, propelled by diversified sales channels and a strategic US expansion highlighted by new flavoured kava shots launched exclusively on Amazon USA.

The Calmer Co. International Limited has launched its Taki Mai kava tinctures on Amazon USA, marking a strategic expansion into a rapidly growing wellness segment. This move aims to capitalize on the booming US tincture market and strengthen the company’s foothold in natural relaxation products.

The Calmer Co. has secured a major retail milestone by launching its Fiji Kava 50g Instant Kava product across Woolworths supermarkets nationwide, significantly broadening its Australian footprint.

The Calmer Co. International Limited has significantly expanded the distribution of its flagship kava products in Coles supermarkets, reflecting growing consumer appetite for natural relaxation alternatives to alcohol.

The Calmer Co. International Limited has successfully closed a renounceable rights issue, raising just over $1 million and issuing hundreds of millions of new shares and options. Directors’ strong participation signals confidence as the company prepares for growth.

The Calmer Co. International Limited has secured a $2.64 million FJD loan from Fiji Development Bank to acquire a key Navua facility, marking a strategic step to bolster its kava processing and staff infrastructure.

The Calmer Co. International Limited has secured a FJD2.64 million loan from Fiji Development Bank to acquire its Navua manufacturing site, marking a strategic step to enhance production and market presence in the global kava industry.

The Calmer Co. International Limited has reported a remarkable surge in sales and cash receipts for the first half of FY25, exceeding the entire FY24 sales. Alongside a strategic CEO transition and factory upgrade, the company is sharpening its focus on profitable growth and cost control.